Vivani Medical manufactures and markets implantable visual prosthetics to enable blind individuals to achieve greater independence. It creates a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa. Through dedication and innovation, Second Sight's mission is to develop, manufacture, and market implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight Medical Products located in Sylmar, California, and was founded in 1998.

Doheny Eye Institute is an American private company located in Los Angeles, CA. The firm provides eye care related research and education programs. Marissa Goldberg is currently the CEO of the company.\nThe company says this about itself: For more than 70 years, Doheny Eye Institute has been at the forefront of vision science. From seeking new ways to free blockages that prevent fluid drainage in glaucoma, to replacing retinal cells in age-related macular degeneration, to providing colleagues worldwide with standardized analyses of anatomical changes in the eyes of patients, Doheny clinician-scientists and researchers are changing how people see �� and also how they think about the future of vision. Doheny Eye Institute and UCLA Stein Eye Institute have joined forces to offer the best patient care, vision research, and education. This affiliation combines the strength, reputation, and distinction of two of the nation's top eye institutions to advance vision research, education, and patient care in California.

Cortigent, Inc. engages in developing targeted neurostimulation systems to help patients recover critical body functions. The company was founded in November 2022 and is headquartered in Valencia, CA.

Engages in the development and domestic implantable medical devices

Nanochap is a biomedical technology developed through core chip research and development. They are regarded as one of the forerunners in the field of resolution artificial retina having been involved in the research of this cutting-edge technology since its inception. They enable clients to monitor human physiological parameters and efficiently analyze personal health status.

Cataract surgery is the single most common procedure performed in the United States annually. Despite technological advancements in both surgical instrumentation and intraocular lens design, approximately 50% of patients are still unable to see well without glasses after surgery. Omega Ophthalmics has developed a new, proprietary lens that will increase the number of “glasses free” post-surgery patients to over 90% by reducing the variables during surgery, revolutionizing a market that has not seen positive, disruptive change in over sixty years. Since the global intraocular lens market has steadily grown and is currently projected to reach $4.3 billion by 2017, the Omega Gemini Refractive Capsule is well-positioned to become the new standard lens for cataract surgery. The Omega Gemini Refractive Capsule is an investigational device and is not approved for use in the United States.

Weizhi Medical Equipment Co., Ltd., established on 2018-03-26, Business scope includes prosthetics,artificial organs and implants(between)into device manufacturing;Prosthetics and Orthotics(assistive devices)production assembly;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Class III Medical Devices,Production of Class II Medical Devices;Class III Medical Devices,Sales of Class II Medical Devices;Class III Medical Devices,R&D of Class II medical devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nano Retina, a joint venture of Zyvex Labs (www.zyvexlabs.com), and Rainbow Medical (www.rainbowmedical.co.il), is developing Bio-Retina, a bionic retina designed to restore sight to those suffering from retinal degenerative diseases. Bio-Retina incorporates various nano-size components in one tiny, flat implant, approximating the size of a child’s fingernail bed. Its simple 30-minute implant procedure requires local anesthesia, a small incision and “gluing” of the device to the damaged retina. Return of sight is anticipated to be instantaneous: 20/200 with the first generation and 20/20 with the second generation product, enabling persons who have undergone the procedure to watch TV and identify faces. Recovery time is estimated at up to one week.

Nanovision Biosciences, Inc. is a private company headquartered in the United States that operates technology company to restore sight to blind patients afflicted with degenerative retinal disorders.

STMicroelectronics is a French-Italian multinational electronics and semiconductor manufacturer headquartered in Geneva, Switzerland. It is commonly called ST, and it is Europe's largest semiconductor chip maker based on revenue. While STMicroelectronics corporate headquarters and the headquarters for EMEA region are based in Geneva, the holding company, STMicroelectronics N.V. is registered in Amsterdam, Netherlands.

Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that for blind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2. Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Shenzhen Zhongke Xianjian Medical Technology Co., Ltd., established on 2018-02-14, Business scope includes general business items:electronic product,Electronic Component,Integrated Chip Design,biomaterials,Computer hardware and software and related technical consulting;Invest in the development of medical devices,electronic,Software and other high-tech industry projects(Specific projects will be reported separately);Technology project investment(Specific projects will be reported separately);Invest in business(Specific projects will be reported separately).(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated),The licensing program is:one type,Class II,Research and development of three types of medical devices,Production and sales and technical consultation.(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations must be licensed before they can be operated)

Topcon, their core business is founded on the surveying instruments they have manufactured since their founding in 1932 and ophthalmic & medical equipment they introduced to the market following World War II. Since then, they have expanded their business domains through a combination of M&A and alliances, including construction machinery control technology since 1994, precision GPS receivers since 2000, precision agriculture since 2006, and mobile control technology since 2007. Today, the world is facing an increase in eye diseases due to global population aging, food shortages caused by global population increase, global infrastructure demands and a shortage of engineering personnel to meet that demand, and continued infrastructure deterioration. In the domains of healthcare, agriculture, and infrastructure, they embraces the slogan "Topcon for Human Life" as they work to expand their business by applying Topcon solutions towards resolving societal challenges.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees.\nThe company has a process oriented quality management system in accordance with ISO 13485.

Gross & Co. provided legal services. The company was headquartered in Suffolk, the United Kingdom.